NORTH
CHICAGO, Ill., Jan. 2, 2024
/PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the 42nd
Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024. Robert A. Michael, president and chief operating
officer, Scott T. Reents, executive
vice president, chief financial officer, Jeffrey R. Stewart, executive vice president,
chief commercial officer and Roopal
Thakkar, M.D. senior vice president, development and
regulatory affairs and chief medical officer, will present at
10:15 a.m. Central time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
and solutions that solve serious health issues today and address
the medical challenges of tomorrow. We strive to have a remarkable
impact on people's lives across several key therapeutic areas –
immunology, oncology, neuroscience, and eye care – and products and
services in our Allergan Aesthetics portfolio. For more information
about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on
LinkedIn, Facebook, Instagram, X (formerly Twitter), and
YouTube.
View original
content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302019269.html
SOURCE AbbVie